← Open Payments lookup

TRACY DZIACKY: Open Payments

NPI 1972257558 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,049 in 44 payments from 18 companies in 2025. Trend: 2023 $132 · 2024 $0 · 2025 $1,049

Food & beverage: $1,049
CompanyPaymentsAmount
Novo Nordisk Inc11$279
Actelion Pharmaceuticals US, Inc.4$158
Astellas Pharma US Inc5$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$96
Lundbeck LLC2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
Otsuka America Pharmaceutical, Inc.1$34
PFIZER INC.2$33
Esperion Therapeutics, Inc.2$32
Kowa Pharmaceuticals America, Inc.2$29

Products named: Wegovy, Veozah, UPTRAVI, CAPLYTA, REXULTI, OPSUMIT, Ozempic, XIFAXAN.

Industry payments across NE — which companies pay providers there.